Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
275.9 USD | +2.85% | -1.24% | -14.57% |
08/05 | UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating | MT |
08/05 | RBC Adjusts Price Target on Bio-Rad Laboratories to $414 From $420 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.57% | 7.71B | |
-4.88% | 183B | |
+0.16% | 108B | |
-3.65% | 67.51B | |
+3.48% | 50.67B | |
+9.12% | 44.7B | |
+2.41% | 40.95B | |
+6.47% | 26.8B | |
+3.75% | 26.71B | |
+12.66% | 24.62B |
- Stock Market
- Equities
- BIO Stock
- News Bio-Rad Laboratories, Inc.
- Zacks Investment Research Lowers Price Target on Bio-Rad Laboratories to $285 From $322